[Federal Register: July 3, 2007 (Volume 72, Number 127)]
[Notices]
[Page 36482]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr03jy07-87]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled Substances; Notice of Application
Pursuant to Sec. 1301.33(a) of Title 21 of the Code of Federal
Regulations (CFR), this is notice that on March 13, 2007, Johnson
Matthey Inc., Custom Pharmaceuticals Department, 2003 Nolte Drive, West
Deptford, New Jersey 08066-1742, made application by letter to the Drug
Enforcement Administration (DEA) to be registered as a bulk
manufacturer of the basic classes of controlled substances listed in
schedule II:
------------------------------------------------------------------------
Drug Schedule
------------------------------------------------------------------------
Cocaine (9041)............................. II
Ecgonine (9180)............................ II
------------------------------------------------------------------------
The company plans on producing cocaine for sale to its customers,
who are final dosage manufacturers. The ecgonine is formed during the
manufacturing process for cocaine.
Any other such applicant and any person who is presently registered
with DEA to manufacture such a substance may file comments or
objections to the issuance of the proposed registration pursuant to 21
CFR 1301.33(a).
Any such written comments or objections being sent via regular mail
should be addressed, in quintuplicate, to the Drug Enforcement
Administrator, Office of Diversion Control, Federal Register
Representative (ODL), Washington, DC 20537; or any being sent via
express mail should be sent to Drug Enforcement Administration, Federal
Register Representative (ODL); 2401 Jefferson Davis Highway,
Alexandria, Virginia 22301; and must be filed no later than September
4, 2007.
Dated: June 26, 2007.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. E7-12947 Filed 7-2-07; 8:45 am]
BILLING CODE 4410-09-P